Item(by='maxharris', descendants=None, kids=None, score=None, time=1610752505, title=None, item_type='comment', url=None, parent=25797526, text='<i>It languished because human trials are expensive and vaccines against rare diseases don&#x27;t make any money.</i><p>Correct. This is because regulations raise the barrier to entry for new drugs to $2.6 billion (in 2019 dollars) <a href="https:&#x2F;&#x2F;www.policymed.com&#x2F;2014&#x2F;12&#x2F;a-tough-road-cost-to-develop-one-new-drug-is-26-billion-approval-rate-for-drugs-entering-clinical-de.html" rel="nofollow">https:&#x2F;&#x2F;www.policymed.com&#x2F;2014&#x2F;12&#x2F;a-tough-road-cost-to-devel...</a><p>Obviously, <i>some</i> amount of testing is necessary to bring a new drug to market (and the examples you point out support this). If there is no alternative but suffering and death for a condition, having these blanket regulations in place that block new drugs and new treatments only contributes to suffering.')